PlainRecalls
FDA Drug Low Class III Terminated

Dexamethasone Sodium Phosphate Injection, USP, 4 mg/mL, 1 mL Vials (NDC 0641-6145-01), packaged in 25 x 1 mL Vials per shelf pack (NDC 0641-6145-25), Rx Only, Manufactured by WEST-WARD, Eatontown, NJ 07724 USA.

Reported: November 29, 2017 Initiated: November 6, 2017 #D-0093-2018

Product Description

Dexamethasone Sodium Phosphate Injection, USP, 4 mg/mL, 1 mL Vials (NDC 0641-6145-01), packaged in 25 x 1 mL Vials per shelf pack (NDC 0641-6145-25), Rx Only, Manufactured by WEST-WARD, Eatontown, NJ 07724 USA.

Reason for Recall

Failed Impurities/Degradation Specifications: high out of specification results for Dexamethasone adduct (related compound).

Details

Units Affected
16,157 shelf packs
Distribution
Nationwide in the USA and Puerto Rico
Location
Eatontown, NJ

Frequently Asked Questions

What product was recalled?
Dexamethasone Sodium Phosphate Injection, USP, 4 mg/mL, 1 mL Vials (NDC 0641-6145-01), packaged in 25 x 1 mL Vials per shelf pack (NDC 0641-6145-25), Rx Only, Manufactured by WEST-WARD, Eatontown, NJ 07724 USA.. Recalled by West-Ward Pharmaceuticals Corp.. Units affected: 16,157 shelf packs.
Why was this product recalled?
Failed Impurities/Degradation Specifications: high out of specification results for Dexamethasone adduct (related compound).
Which agency issued this recall?
This recall was issued by the FDA Drug on November 29, 2017. Severity: Low. Recall number: D-0093-2018.